Vancouver, British Columbia–(Newsfile Corp. – June 5, 2026) – The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the “Company” or “BPC”), is pleased to announce that, further to its news release dated October 15, 2025, it has extended its existing agreement with Emerging Markets Consulting, LLC (“EMC”) for the continued provision of investor relations and communication services by EMC for an additional six month term. Emerging Markets Consulting, LLC Based in Orlando, Florida, EMC brings multiple decades of combined experience in the investor relations industry.
This excerpt is quoted from the original release. Read the full announcement on Newsfile Corp.
Brief Summary
Vancouver, British Columbia — The Precision Peptide Company (CSE: BPC) has successfully extended its investor relations agreement with Emerging Markets Consulting, LLC (EMC) for an additional six months. This partnership enhances the company’s communication strategy as they continue to engage with their growing investor base.
- Expertise: EMC offers decades of investor relations experience.
- Duration: Extension for six months, effective immediately.
- Objective: To boost investor engagement and communication strategies.
- Location: Orlando, Florida, a hub for investor relations.
Why it matters: This extension is crucial for BPC as it strengthens its investor relations efforts, aiding in transparency and proactive communication.
Read the Full Article
This is a summary of the press release. For the complete article and any additional details, please visit the original source.
Attribution: Original press release by Newsfile Corp on . We provide an AI-generated summary and links for convenience. Always verify details with the original source. Not investment advice. For informational purposes only.